Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
D000721:Ancrod / Q000627:therapeutic use; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D012103:Batroxobin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005341:Fibrinolysin / Q000627:therapeutic use; D006405:Hematology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D009203:Myocardial Infarction / Q000188:drug therapy; D010958:Plasminogen / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000188:drug therapy; D012042:Registries; D012106:Research; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications; D013300:Streptokinase / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013552:Swine; D013924:Thrombophlebitis / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D010958:Plasminogen; D006493:Heparin; D013300:Streptokinase; D000721:Ancrod; D012103:Batroxobin; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator; D001241:Aspirin; D013442:Sulfinpyrazone